137 related articles for article (PubMed ID: 15485699)
1. Monitoring the response to antiretroviral therapy in resource-poor settings: the Malawi model.
Harries AD; Gomani P; Teck R; de Teck OA; Bakali E; Zachariah R; Libamba E; Mwansambo A; Salaniponi F; Mpazanje R
Trans R Soc Trop Med Hyg; 2004 Dec; 98(12):695-701. PubMed ID: 15485699
[TBL] [Abstract][Full Text] [Related]
2. Assessment of a national monitoring and evaluation system for rapid expansion of antiretroviral treatment in Malawi.
Lowrance D; Filler S; Makombe S; Harries A; Aberle-Grasse J; Hochgesang M; Libamba E
Trop Med Int Health; 2007 Mar; 12(3):377-81. PubMed ID: 17313509
[TBL] [Abstract][Full Text] [Related]
3. Scaling up antiretroviral therapy in Africa: learning from tuberculosis control programmes--the case of Malawi.
Libamba E; Makombe S; Harries AD; Chimzizi R; Salaniponi FM; Schouten EJ; Mpazanje R
Int J Tuberc Lung Dis; 2005 Oct; 9(10):1062-71. PubMed ID: 16229216
[TBL] [Abstract][Full Text] [Related]
4. Can we get more HIV-positive tuberculosis patients on antiretroviral treatment in a rural district of Malawi?
Zachariah R; Teck R; Ascurra O; Gomani P; Manzi M; Humblet P; Nunn P; Salaniponi FM; Harries AD
Int J Tuberc Lung Dis; 2005 Mar; 9(3):238-47. PubMed ID: 15786885
[TBL] [Abstract][Full Text] [Related]
5. Voluntary counselling, HIV testing and adjunctive cotrimoxazole are associated with improved TB treatment outcomes under routine conditions in Thyolo District, Malawi.
Chimzizi R; Gausi F; Bwanali A; Mbalume D; Teck R; Gomani P; Zachariah R; Zuza W; Malombe R; Salaniponi FM; Harries AD
Int J Tuberc Lung Dis; 2004 May; 8(5):579-85. PubMed ID: 15137534
[TBL] [Abstract][Full Text] [Related]
6. Ethical and programmatic challenges in antiretroviral scaling-up in Malawi: challenges in meeting the World Health Organization's "Treating 3 million by 2005" initiative goals.
Muula AS
Croat Med J; 2004 Aug; 45(4):415-21. PubMed ID: 15311413
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of patients with Kaposi's sarcoma who start antiretroviral therapy under routine programme conditions in Malawi.
Makombe SD; Harries AD; Yu JK; Hochgesang M; Mhango E; Weigel R; Pasulani O; Fitzgerald M; Schouten EJ; Libamba E
Trop Doct; 2008 Jan; 38(1):5-7. PubMed ID: 18302849
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of tuberculosis patients who start antiretroviral therapy under routine programme conditions in Malawi.
Makombe SD; Harries AD; Yu JK; Hochgesang M; Mhango E; Weigel R; Pasulani O; Fitzgerald M; Schouten EJ; Libamba E
Int J Tuberc Lung Dis; 2007 Apr; 11(4):412-6. PubMed ID: 17394687
[TBL] [Abstract][Full Text] [Related]
9. Antiretroviral therapy for children in the routine setting in Malawi.
Malawi Paediatric Antiretroviral Treatment Group
Trans R Soc Trop Med Hyg; 2007 May; 101(5):511-6. PubMed ID: 17197006
[TBL] [Abstract][Full Text] [Related]
10. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.
Jordan MR; Bennett DE; Bertagnolio S; Gilks CF; Sutherland D
Antivir Ther; 2008; 13 Suppl 2():15-23. PubMed ID: 18575188
[TBL] [Abstract][Full Text] [Related]
11. [HIV and tuberculosis: new perspectives for diagnosis and treatment].
Zellweger JP
Rev Med Suisse; 2006 Nov; 2(87):2616-9. PubMed ID: 17343152
[TBL] [Abstract][Full Text] [Related]
12. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
13. Review editorial: prevention of tuberculosis in resource-poor countries with increasing access to highly active antiretroviral treatment.
Apers L; Lynen L; Worodria W; Colebunders R
Trop Med Int Health; 2005 Dec; 10(12):1209-14. PubMed ID: 16359399
[TBL] [Abstract][Full Text] [Related]
14. Health systems and access to antiretroviral drugs for HIV in Southern Africa: service delivery and human resources challenges.
Schneider H; Blaauw D; Gilson L; Chabikuli N; Goudge J
Reprod Health Matters; 2006 May; 14(27):12-23. PubMed ID: 16713875
[TBL] [Abstract][Full Text] [Related]
15. Peripheral neuropathy in HIV-positive patients at an antiretroviral clinic in Lilongwe, Malawi.
Beadles WI; Jahn A; Weigel R; Clutterbuck D
Trop Doct; 2009 Apr; 39(2):78-80. PubMed ID: 19299286
[TBL] [Abstract][Full Text] [Related]
16. Adherence to TB preventive therapy for HIV-positive patients in rural South Africa: implications for antiretroviral delivery in resource-poor settings?
Rowe KA; Makhubele B; Hargreaves JR; Porter JD; Hausler HP; Pronyk PM
Int J Tuberc Lung Dis; 2005 Mar; 9(3):263-9. PubMed ID: 15786888
[TBL] [Abstract][Full Text] [Related]
17. Management of adults living with HIV/AIDS in low-income, high-burden settings, with special reference to persons with tuberculosis.
Fujiwara PI; Clevenbergh P; Dlodlo RA
Int J Tuberc Lung Dis; 2005 Sep; 9(9):946-58. PubMed ID: 16158886
[TBL] [Abstract][Full Text] [Related]
18. Use of antiretroviral therapy in resource-limited countries in 2006: distribution and uptake of first- and second-line regimens.
Renaud-Théry F; Nguimfack BD; Vitoria M; Lee E; Graaff P; Samb B; Perriëns J
AIDS; 2007 Jul; 21 Suppl 4():S89-95. PubMed ID: 17620758
[TBL] [Abstract][Full Text] [Related]
19. Early warning indicators for HIV drug resistance in Malawi.
Hedt BL; Wadonda-Kabondo N; Makombe S; Harries AD; Schouten EJ; Limbambala E; Hochgesang M; Aberle-Grosse J; Kamoto K
Antivir Ther; 2008; 13 Suppl 2():69-75. PubMed ID: 18575193
[TBL] [Abstract][Full Text] [Related]
20. Surveillance of transmitted HIV drug resistance with the World Health Organization threshold survey method in Lilongwe, Malawi.
Kamoto K; Aberle-Grasse J;
Antivir Ther; 2008; 13 Suppl 2():83-7. PubMed ID: 18575195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
